HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2,5- dibromo- 2- (beta- naphthyl)indan- 1,3- dione

Also Known As:
43-63; 2,5-dibromo-2-(2-naphthalenyl)-1H-indene-1,3(2H)-dione
Networked: 65 relevant articles (3 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Myasoedova, E I: 2 articles (07/2019 - 05/2019)
2. Fung, Teresa T: 2 articles (01/2018 - 01/2016)
3. Hu, Frank B: 2 articles (01/2018 - 01/2016)
4. Willett, Walter C: 2 articles (01/2018 - 01/2016)
5. Mazzoccoli, Gianluigi: 2 articles (12/2012 - 10/2011)
6. Heegaard, Steffen: 1 article (09/2022)
7. Kessel, Line: 1 article (09/2022)
8. Toft, Peter Bjerre: 1 article (09/2022)
9. Turanzas, Nathali J: 1 article (09/2022)
10. Wiencke, Anne Katrine: 1 article (09/2022)

Related Diseases

1. Pain (Aches)
11/01/2009 - "Mean improvement in the preoperative to postoperative scores was significant for the Lysholm (37-63, P <.001), International Knee Documentation Committee (31-57, P <.001), KOOS Pain (48-71, P <.001), KOOS Symptoms (51-70, P <.001), KOOS Activities of Daily Living (60-80, P <.001), KOOS Sport (25-42, P <.001), KOOS Quality of Life (24-49, P <.001), Short Form-12 Physical (38-41, P <.05), Cincinnati (43-63, P <.005), and Tegner (4-6, P <.05), but not for the Short Form-12 Mental. "
08/01/2007 - "The most frequent bone-related manifestations at study entry were osteoporosis (43/63 [68%] patients) and bone pain (41/65 [63%] patients). "
02/01/2016 - "Rectal pain intensity (VAS 0-100) during identical distension pressures increased from 39 (95% confidence interval: 35-42) outside the scanner to 53 (43-63) inside the scanner in irritable bowel syndrome, and from 42 (31-52) to 49 (39-58), respectively, in controls (ANOVA for scanner effect: p = 0.006, group effect: p = 0.92). "
03/10/1990 - "43 (63%) on iloprost treatment had complete relief of pain, compared with 18 (28%) on aspirin. "
01/01/2020 - "The 3 most frequently reported domains were in the surrogate category: kidney function (54; 79% of trials; using 46 measures), kidney and cyst volumes (43; 63% of trials; 52 measures), and blood pressure (27; 40% of trials, 30 measures); in the clinical category: infection (10; 15%; 21 measures), cardiovascular events (9; 13%; 6 measures), and kidney failure requiring kidney replacement therapy (8; 12%; 5 measures); and in the patient-reported category: pain related to ADPKD (16; 24%; 26 measures), pain for other reasons (11; 16%; 11 measures), and diarrhea/constipation/gas (10; 15%; 9 measures). "
2. Cognitive Dysfunction
3. Weight Loss (Weight Reduction)
4. Infections
5. Renal Insufficiency (Renal Failure)

Related Drugs and Biologics

1. Antidepressive Agents (Antidepressants)
2. Lamotrigine (Lamictal)
3. Gelsolin
4. Iloprost (Ventavis)
5. Triglycerides (Triacylglycerol)
6. Thyroxine (Levothyroxine)
7. Thyrotropin-Releasing Hormone (Protirelin)
8. Thyrotropin (Thyroid-Stimulating Hormone)
9. Oxygen (Dioxygen)
10. Melatonin

Related Therapies and Procedures

1. Activities of Daily Living (ADL)
2. Renal Replacement Therapy (Therapies, Renal Replacement)
3. Norwood Procedures
4. Therapeutics
5. Operative Surgical Procedures